icon
View Focus Area

Genomic Tumor Board ECHO

December 2023

-

November 2024

Case Presentation Submission Form

Click here to submit your Case Presentation

Enter CODE: 84XRAY7DH

 

Please Email Susan.Halverson@JAX.org with your preferred case presentation date.

 

Top things to know about biomarker testing

Didactic Presenters

Kate Reed MPH, ScM, CGC

Indications for germline testing

Didactic Presenters

Kate Reed MPH, ScM, CGC

Interpreting results: Know when further testing is needed

Didactic Presenters

Kate Reed MPH, ScM, CGC

Homologous recombination deficiency (HRD) overview 

Didactic Presenters

Kate Reed MPH, ScM, CGC

Accessing targeted treatments (off-label and clinical trials)

Didactic Presenters

Lindsey Kelley, MPH, CGC

Use of PARP inhibitors in non-canonical cancer types

Didactic Presenters

Christine Walko Pharm.D. 

EGFR inhibitor Resistance

Didactic Presenters

Todd Knepper, Pharm.D.

Lynch syndrome & young onset colorectal cancer 

Targeting KRAS pathway

Microsatellite instability and tumor mutational burden

Our Experts

expert-head-shot

Christine Walko Pharm.D. 

Senior Member in the Department of Pathology Center

Program Leader for Precision Medicine

Attending on the Precision Medicine Clinical Service

expert-head-shot

Todd Knepper, Pharm.D.

Assoc. Member in the Department of Pathology Center

expert-head-shot

Jens Rueter, MD

expert-head-shot

Kate Reed MPH, ScM, CGC

Director, Precision Oncology Education

expert-head-shot

Leah Graham, PhD

Associate Director, MCGI

expert-head-shot

Lindsey Kelley, MPH, CGC

expert-head-shot

Susan Halverson

Genomic Tumor Board Coordinator, MCGI

Collected Program Resources

This Website is administered by the American Cancer Society, Inc. on behalf of the Office of Cancer Research & Implementation. Copyright © 2023 American Cancer Society ECHO American Cancer Society, Inc.

Privacy Policy